Radon and lung cancer: assessing and mitigating the risk

Humberto Choi; Peter Mazzone

doi:10.3949/ccjm.81a.14046

Radon and lung cancer: assessing and mitigating the risk

Cleve Clin J Med. 2014 Sep;81(9):567-75. doi: 10.3949/ccjm.81a.14046.

Authors

Humberto Choi¹, Peter Mazzone²

Affiliations

¹ Departments of Pulmonary Medicine and Critical Care Medicine, Respiratory Institute, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH [email protected].
² Departments of Pulmonary Medicine, Critical Care Medicine, and Transplantation Center, Respiratory Institute, Cleveland Clinic.

PMID: 25183848
DOI: 10.3949/ccjm.81a.14046

Abstract

Radon is a naturally occurring radioactive gas. Its progenies emit alpha particles capable of causing tissue damage. Radon exposure is estimated to be the second most common cause of lung cancer in the United States. Management of patients with a history of radon exposure should involve a lung cancer specialist.

Publication types

Review

MeSH terms

Air Pollution, Indoor / adverse effects*
Air Pollution, Indoor / prevention & control
Air Pollution, Radioactive / adverse effects*
Air Pollution, Radioactive / prevention & control
Early Detection of Cancer
Housing / standards
Humans
Lung Neoplasms / chemically induced*
Lung Neoplasms / diagnosis
Lung Neoplasms / epidemiology
Lung Neoplasms / prevention & control*
Radon / toxicity*
Risk Assessment
United States / epidemiology

Substances

Radon